Cetera Advisor Networks LLC Has $1.01 Million Stake in Aetna Inc (AET)
Cetera Advisor Networks LLC reduced its holdings in shares of Aetna Inc (NYSE:AET) by 5.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,312 shares of the company’s stock after selling 344 shares during the quarter. Cetera Advisor Networks LLC’s holdings in Aetna were worth $1,006,000 as of its most recent filing with the SEC.
Several other large investors have also added to or reduced their stakes in AET. Bruderman Asset Management LLC acquired a new stake in shares of Aetna in the 2nd quarter valued at about $106,000. Lloyds Banking Group plc acquired a new stake in shares of Aetna in the 3rd quarter valued at about $106,000. Moisand Fitzgerald Tamayo LLC acquired a new stake in shares of Aetna in the 3rd quarter valued at about $116,000. Westside Investment Management Inc. boosted its position in shares of Aetna by 53.5% in the 2nd quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after purchasing an additional 400 shares during the period. Finally, Phocas Financial Corp. acquired a new stake in shares of Aetna in the 2nd quarter valued at about $182,000. 88.01% of the stock is owned by institutional investors and hedge funds.
In other news, President Karen S. Lynch sold 15,271 shares of the stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
A number of analysts recently issued reports on AET shares. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $174.00 target price for the company in a research report on Thursday, October 12th. Argus cut Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price for the company. in a research report on Wednesday, December 6th. Jefferies Group upped their target price on Aetna from $165.00 to $185.00 and gave the company a “hold” rating in a research report on Wednesday, November 1st. BMO Capital Markets started coverage on Aetna in a research report on Monday, October 16th. They issued a “market perform” rating and a $175.00 target price for the company. Finally, Credit Suisse Group reissued a “neutral” rating and issued a $195.00 target price (up from $174.00) on shares of Aetna in a research report on Wednesday, December 6th. Twelve analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Aetna presently has a consensus rating of “Buy” and an average target price of $175.19.
Aetna Inc (NYSE:AET) opened at $179.11 on Thursday. The stock has a market capitalization of $59,138.27, a P/E ratio of 17.76, a PEG ratio of 1.65 and a beta of 0.61. Aetna Inc has a one year low of $116.04 and a one year high of $192.37. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53.
Aetna (NYSE:AET) last issued its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.06 by $0.39. The business had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company’s revenue for the quarter was down 5.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.07 EPS. research analysts anticipate that Aetna Inc will post 9.78 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date is Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is 37.04%.
TRADEMARK VIOLATION WARNING: “Cetera Advisor Networks LLC Has $1.01 Million Stake in Aetna Inc (AET)” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.watchlistnews.com/cetera-advisor-networks-llc-has-1-01-million-stake-in-aetna-inc-aet/1763122.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with Analyst Ratings Network's FREE daily email newsletter.